Literature DB >> 32093884

HLA-G and humanized mouse models as a novel therapeutic approach in transplantation.

Ashwin Ajith1, Vera Portik-Dobos1, Daniel D Horuzsko2, Rajan Kapoor3, Laura L Mulloy3, Anatolij Horuzsko4.   

Abstract

HLA-G is a nonclassical MHC-Class I molecule whose expression, along the feto-maternal barrier contributes towards tolerance of the semiallogeneic fetus during pregnancy. In light of its inhibitory properties, recent research has established HLA-G involvement in mechanisms responsible for directing allogeneic immune responses towards tolerance during allogeneic situations such as organ transplantation. Here, we critically review the data supporting the tolerogenic role of HLA-G in organ transplantation, the various factors influencing its expression, and the introduction of novel humanized mouse models that are one of the best approaches to assess the utility of HLA-G as a therapeutic tool in organ transplantation.
Copyright © 2020 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HLA-G; Humanized mouse model; Rejection; Transplantation

Mesh:

Substances:

Year:  2020        PMID: 32093884      PMCID: PMC8672853          DOI: 10.1016/j.humimm.2020.02.006

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  77 in total

Review 1.  The LILR family: modulators of innate and adaptive immune pathways in health and disease.

Authors:  D Brown; J Trowsdale; R Allen
Journal:  Tissue Antigens       Date:  2004-09

2.  Elevated levels of soluble non-classical major histocompatibility class I molecule human leucocyte antigen (HLA)-G in the blood of HIV-infected patients with or without visceral leishmaniasis.

Authors:  L Donaghy; F Gros; L Amiot; C Mary; A Maillard; C Guiguen; J-P Gangneux
Journal:  Clin Exp Immunol       Date:  2007-02       Impact factor: 4.330

3.  A comprehensive study of polymorphic sites along the HLA-G gene: implication for gene regulation and evolution.

Authors:  Erick C Castelli; Celso T Mendes-Junior; Luciana C Veiga-Castelli; Michel Roger; Philippe Moreau; Eduardo A Donadi
Journal:  Mol Biol Evol       Date:  2011-05-28       Impact factor: 16.240

4.  Cutting Edge: Class II-like Structural Features and Strong Receptor Binding of the Nonclassical HLA-G2 Isoform Homodimer.

Authors:  Kimiko Kuroki; Kazuhiro Mio; Ami Takahashi; Haruki Matsubara; Yoshiyuki Kasai; Sachie Manaka; Masahide Kikkawa; Daizo Hamada; Chikara Sato; Katsumi Maenaka
Journal:  J Immunol       Date:  2017-03-27       Impact factor: 5.422

5.  Disulfide bond-mediated dimerization of HLA-G on the cell surface.

Authors:  Jonathan E Boyson; Robert Erskine; Mary C Whitman; Michael Chiu; Julie M Lau; Louise A Koopman; Markus M Valter; Pavla Angelisova; Vaclav Horejsi; Jack L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-26       Impact factor: 11.205

6.  CD3+CD4low and CD3+CD8low are induced by HLA-G: novel human peripheral blood suppressor T-cell subsets involved in transplant acceptance.

Authors:  Abderrahim Naji; Solene Le Rond; Antoine Durrbach; Irene Krawice-Radanne; Caroline Creput; Marina Daouya; Julien Caumartin; Joel LeMaoult; Edgardo D Carosella; Nathalie Rouas-Freiss
Journal:  Blood       Date:  2007-09-05       Impact factor: 22.113

7.  Myocardial HLA-G reliably indicates a low risk of acute cellular rejection in heart transplant recipients.

Authors:  Rohit Sheshgiri; Nathalie Rouas-Freiss; Vivek Rao; Jagdish Butany; Danny Ramzy; Irene Krawice-Radanne; Heather J Ross; Edgardo D Carosella; Diego H Delgado
Journal:  J Heart Lung Transplant       Date:  2008-05       Impact factor: 10.247

8.  HLA-G expression levels influence the tolerogenic activity of human DC-10.

Authors:  Giada Amodio; Michela Comi; Daniela Tomasoni; Monica Emma Gianolini; Roberta Rizzo; Joël LeMaoult; Maria-Grazia Roncarolo; Silvia Gregori
Journal:  Haematologica       Date:  2015-02-06       Impact factor: 9.941

9.  KIR2DL4 (CD158d): An activation receptor for HLA-G.

Authors:  Sumati Rajagopalan; Eric O Long
Journal:  Front Immunol       Date:  2012-08-20       Impact factor: 7.561

10.  Practice Patterns in the Treatment and Monitoring of Acute T Cell-Mediated Kidney Graft Rejection in Canada.

Authors:  Julie Leblanc; Peter Subrt; Michèle Paré; David Hartell; Lynne Sénécal; Tom Blydt-Hansen; Héloïse Cardinal
Journal:  Can J Kidney Health Dis       Date:  2018-02-15
View more
  2 in total

Review 1.  HLA-G: An Important Mediator of Maternal-Fetal Immune-Tolerance.

Authors:  Baimei Zhuang; Jin Shang; Yuanqing Yao
Journal:  Front Immunol       Date:  2021-10-29       Impact factor: 7.561

2.  Humanized Mouse Model as a Novel Approach in the Assessment of Human Allogeneic Responses in Organ Transplantation.

Authors:  Ashwin Ajith; Laura L Mulloy; Md Abu Musa; Valia Bravo-Egana; Daniel David Horuzsko; Imran Gani; Anatolij Horuzsko
Journal:  Front Immunol       Date:  2021-06-11       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.